CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • AACR 2022 Preview: Decoding Cancer Complexity, Integrating Science, and Transforming Patient Outcomes

    During AACR’s upcoming 2022 annual meeting, CRI scientists will share the latest advances in cancer immunotherapy.

    April 1, 2022| Arthur N. Brodsky, PhD
  • Mining the Mysteries of Myeloid Cells with CRI Lloyd J. Old STAR Malay Haldar

    CRI Lloyd J. Old STAR Malay Haldar is exploring the role of dendritic cells and macrophages in…

    March 28, 2022| Arthur N. Brodsky, PhD
  • Neutrophils and Inflammation in Colorectal Cancer with CRI Lloyd J. Old STAR Ivan Zanoni

    CRI Lloyd J. Old STAR Ivan Zanoni is exploring the multifaceted roles of neutrophils in colorectal cancer.

    March 21, 2022| Arthur N. Brodsky, PhD
  • Novel CAR Immunotherapies for Pancreatic Cancer with Dr. Ryan Alexander

    CRI Fellow Ryan Alexander is developing new cellular immunotherapies for pancreatic cancer.

    March 7, 2022| Arthur N. Brodsky, PhD
  • Overcoming Immune Dysfunction in Brain Cancer with CRI Lloyd J. Old STAR Peter Fecci

    CRI Arash Ferdowsi Lloyd J. Old STAR Peter Fecci is seeking to characterize and develop ways to…

    February 14, 2022| Arthur N. Brodsky, PhD
  • Engineering Bacteria to Improve Cancer Immunotherapy with CRI Lloyd J. Old STAR Tal Danino

    CRI Lloyd J. Old STAR Tal Danino is exploring how to engineer bacteria to help our bodies…

    January 24, 2022| Arthur N. Brodsky, PhD
  • COVID-19 and Cancer Vaccines with Immunotherapy Pioneers Ugur Sahin and Özlem Türeci

    Ugur Sahin and Ozlem Tureci, two of this year’s CRI Coley Award recipients, are pioneers of the…

    December 21, 2021| Arthur N. Brodsky, PhD
  • Improving Cell Therapies by Characterizing Our Immune Arsenal with CRI STAR Dr. Ning Jenny Jiang

    Dr. Ning Jenny Jiang, a CRI Lloyd J. Old STAR at the University of Pennsylvania, is working to…

    November 30, 2021| Arthur N. Brodsky, PhD
  • Sarcoma Awareness Month: Tackling Chordoma with Dr. Cassian Yee

    CRI-Chordoma Foundation CLIP Investigator Dr. Cassian Yee is exploring how to design cell therapies for patients with…

    July 1, 2021| Arthur N. Brodsky, PhD

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute